What are biomarkers of malignancy of multiple myeloma?

Updated: Sep 12, 2018
  • Author: Mohammad I Abu Zaid, MBBS; Chief Editor: Emmanuel C Besa, MD  more...
  • Print


Biomarkers of malignancy are as follows:

  • Clonal bone marrow plasma cell percentage ≥60%
  • Involved:uninvolved serum free light chain ratio ≥100
  • More than 1 focal lesion on MRI studies

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!